Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma

Clinical trial NCT01217229 · COMPLETED

Trial details

NCT number: NCT01217229
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2011-03-03
Primary completion: 2012-04-26
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.